Redistributed versus homogenous radiotherapy dose for head and neck cancer; a treatment planning study

[1]  M. Guckenberger,et al.  Evaluation of an automated knowledge based treatment planning system for head and neck , 2015, Radiation oncology.

[2]  Johannes A Langendijk,et al.  Advances in Radiotherapy for Head and Neck Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Anne Bol,et al.  Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: A planning study , 2015, Acta oncologica.

[4]  S. Korreman,et al.  Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Quynh-Thu Le,et al.  Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Wei Wang,et al.  Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. , 2013, International journal of radiation oncology, biology, physics.

[7]  Jan-Jakob Sonke,et al.  Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer , 2013, BMC Cancer.

[8]  Lei Dong,et al.  Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. , 2012, International journal of radiation oncology, biology, physics.

[9]  D. Rietveld,et al.  Five‐year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra‐arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer , 2012, Head & neck.

[10]  Fréderic Duprez,et al.  Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Claus F. Behrens,et al.  The feasibility of using Pareto fronts for comparison of treatment planning systems and delivery techniques , 2009, Acta oncologica.

[13]  M. Kessler,et al.  Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  N. Aaronson,et al.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Schwaiger,et al.  Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.